Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMbrella C
NCT05112965Phase 3Active, not recruiting
- Sponsor
- Roche
- Start
- Dec 2021
- Primary completion
- Jun 2027
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of atezolizumab in Neoplasm, sponsored by Roche. Started Dec 2021; status: active, not recruiting.
02
Drugs
atezolizumab
03
Conditions
Neoplasm
Beyond the preview
Go deeper on NCT05112965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05112965.